Needham Downgrades Axonics to Hold
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has downgraded Axonics (NASDAQ:AXNX) from Buy to Hold, indicating a shift in the firm's outlook on the company's stock.
January 17, 2024 | 11:01 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Axonics has been downgraded by Needham analyst Mike Matson from Buy to Hold, which may influence investor sentiment and potentially impact the stock's performance in the short term.
Downgrades by analysts can lead to a negative perception among investors and may result in a decrease in stock price in the short term as market participants reassess the company's prospects.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100